DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care

Launched by DAVID BLUM · Sep 23, 2024

Keywords

ClinConnect Summary

The DigiPall trial is a study designed to see if using a special system can help patients with advanced cancer or severe illnesses feel better and avoid unnecessary hospital visits. This system includes a wearable device that tracks heartbeats and steps, along with a smartphone chatbot that checks in with patients daily about their symptoms and provides helpful tips. The goal is to improve overall well-being for those receiving palliative care, which focuses on comfort and quality of life.

To participate, patients need to be at least 18 years old and have a diagnosis of metastatic cancer or a severe illness with a limited life expectancy of less than 24 months. They should also be able to use a smartphone and have a certain level of physical and mental ability. Participants can expect daily interactions through the smartphone chatbot and the use of the wearable device to monitor their health. It's important to note that this study is not for patients who are receiving treatment aimed at curing their illness or who have significant cognitive impairment. The trial is not yet recruiting participants, but it aims to help improve the care and support for patients in their final stages of life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy receiving palliative care services
• • Estimated life expectancy \<24 months (physician's guess)/ \>3 months
• • Karnofsky Index ≥ 50% / ECOG≤ 2
• • Aged \>18 years
• • Owns and uses a smartphone
• • Give written informed consent
• Exclusion Criteria:
• • Patients under curative treatment
• • Relevant cognitive impairment